Olivier Legrain is a businessperson who has been at the head of 6 different companies and presently holds the position of Chief Executive Officer, Director & MD at Ion Beam Applications SA and Chairman for SOFIE Co., Chairman of IBA Proton Therapy Canada, Inc. and Co-Managing Director at IBA Dosimetry GmbH (which are all subsidiaries of Ion Beam Applications SA). Mr. Legrain is also on the board of IBA Molecular Holding SA.

He previously occupied the position of Chief Executive Officer of Scanditronix Medical Ab, Chief Strategy Officer at IBA Molecular Holding SA and President of Zevacor Pharma, Inc.

Mr. Legrain received an undergraduate degree from Vrije Universiteit Brussel.